Only a small percentage of older adults with early Alzheimer's eligible for new treatments - News-Medical.Net
news-medical.netSubmitted by newsmedicalnet3723 in health
Only a small percentage of older adults who are in the early stages of Alzheimer's disease meet the eligibility criteria to receive new monoclonal antibody treatments, drugs that target amyloid-ß plaques in the brain, an early sign of Alzheimer's disease.